Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
RETRACTION: PLAGL2 Promotes the Stemness and is Upregulated by Transcription Factor E2F1 in Human Lung Cancer
Retraction:
Y. Lin, P. Lin, W. Guo, J. Huang, X. Xu, and X. Zhuang, "PLAGL2 Promotes the Stemness and is Upregulated by Transcription Factor E2F1 in Human Lung Cancer," Environmental Toxicology 38, no. 4 (2023): 941-949, https://doi.org/10.1002/tox.23739. The above article, published online on 09 January 2023 in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, April Rodd; and Wiley Periodicals LLC. Following an investigation by the publisher, the parties have concluded that this article was accepted solely on the basis of a compromised peer review process. Therefore, the article must be retracted. The authors did not respond to communications from the Publisher regarding the retraction.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Induced Pluripotent Stem Cells
Somatic...
Maintenance of the ES Cell State
Abnormal Proliferation
Cell Specific Gene Expression
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

